Cargando…
TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer
SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aime...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430641/ https://www.ncbi.nlm.nih.gov/pubmed/34503204 http://dx.doi.org/10.3390/cancers13174394 |
_version_ | 1783750750874107904 |
---|---|
author | Lecuelle, Julie Boidot, Romain Mananet, Hugo Derangère, Valentin Albuisson, Juliette Goussot, Vincent Arnould, Laurent Tharin, Zoé Ray Coquard, Isabelle Ghiringhelli, François Truntzer, Caroline Fumet, Jean-David |
author_facet | Lecuelle, Julie Boidot, Romain Mananet, Hugo Derangère, Valentin Albuisson, Juliette Goussot, Vincent Arnould, Laurent Tharin, Zoé Ray Coquard, Isabelle Ghiringhelli, François Truntzer, Caroline Fumet, Jean-David |
author_sort | Lecuelle, Julie |
collection | PubMed |
description | SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aimed to investigate immune parameters according to genomic instability signatures. We observed that homologous recombination deficiency positive, copy cumber variant signature 7 and TCR (T cells receptor) clonality are good prognostic biomarkers in HGSC. Combining TCR clonality and genomic instability signature or T cell infiltration improved the prognostic value compared to each variable taken alone. We provided a description of immune parameters according to different genomic instability signatures. We identified TCR clonality, alone or combined with genomic instability, as a promising prognostic biomarker in HGSC. ABSTRACT: Purpose: Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate exome-derived parameters to assess the tumor microenvironment according to genomic instability profile. Methods: We used the HGSC TCGA (the cancer genome atlas) dataset with genomic characteristics, including homologous recombination deficiency (HRD), copy number variant (CNV) signatures, TCR (T cell receptor) clonality and abundance of tissue-infiltrating immune and stromal cell populations. We then investigated the relationship with survival data. Results: In 578 HGSC patients, HRD status, CNV signature 7 and TCR clonality were associated with longer survival. The combination of high CNV signature 7 expression and HRD status or high CNV signature 3 expression and high TCR clonality was associated with a trend towards longer survival compared to each variable alone. Combining T cell infiltrate and TCR clonality improved the prognostic value compared to T cells infiltration alone. Prognostic value of TCR clonality was confirmed in an independent cohort. Conclusions: TCR clonality is an emerging prognostic biomarker that improves T cell infiltrate information. Analysis of TCR clonality combined with genomic instability could be an interesting prognostic biomarker. |
format | Online Article Text |
id | pubmed-8430641 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84306412021-09-11 TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer Lecuelle, Julie Boidot, Romain Mananet, Hugo Derangère, Valentin Albuisson, Juliette Goussot, Vincent Arnould, Laurent Tharin, Zoé Ray Coquard, Isabelle Ghiringhelli, François Truntzer, Caroline Fumet, Jean-David Cancers (Basel) Article SIMPLE SUMMARY: High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate is known to be a robust biomarker in HGSC. We aimed to investigate immune parameters according to genomic instability signatures. We observed that homologous recombination deficiency positive, copy cumber variant signature 7 and TCR (T cells receptor) clonality are good prognostic biomarkers in HGSC. Combining TCR clonality and genomic instability signature or T cell infiltration improved the prognostic value compared to each variable taken alone. We provided a description of immune parameters according to different genomic instability signatures. We identified TCR clonality, alone or combined with genomic instability, as a promising prognostic biomarker in HGSC. ABSTRACT: Purpose: Immune infiltration is a prognostic factor in high-grade serous ovarian carcinoma (HGSC) but immunotherapy efficacy is disappointing. Genomic instability is now used to guide the therapeutic value of PARP inhibitors. We aimed to investigate exome-derived parameters to assess the tumor microenvironment according to genomic instability profile. Methods: We used the HGSC TCGA (the cancer genome atlas) dataset with genomic characteristics, including homologous recombination deficiency (HRD), copy number variant (CNV) signatures, TCR (T cell receptor) clonality and abundance of tissue-infiltrating immune and stromal cell populations. We then investigated the relationship with survival data. Results: In 578 HGSC patients, HRD status, CNV signature 7 and TCR clonality were associated with longer survival. The combination of high CNV signature 7 expression and HRD status or high CNV signature 3 expression and high TCR clonality was associated with a trend towards longer survival compared to each variable alone. Combining T cell infiltrate and TCR clonality improved the prognostic value compared to T cells infiltration alone. Prognostic value of TCR clonality was confirmed in an independent cohort. Conclusions: TCR clonality is an emerging prognostic biomarker that improves T cell infiltrate information. Analysis of TCR clonality combined with genomic instability could be an interesting prognostic biomarker. MDPI 2021-08-31 /pmc/articles/PMC8430641/ /pubmed/34503204 http://dx.doi.org/10.3390/cancers13174394 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lecuelle, Julie Boidot, Romain Mananet, Hugo Derangère, Valentin Albuisson, Juliette Goussot, Vincent Arnould, Laurent Tharin, Zoé Ray Coquard, Isabelle Ghiringhelli, François Truntzer, Caroline Fumet, Jean-David TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title | TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title_full | TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title_fullStr | TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title_full_unstemmed | TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title_short | TCR Clonality and Genomic Instability Signatures as Prognostic Biomarkers in High Grade Serous Ovarian Cancer |
title_sort | tcr clonality and genomic instability signatures as prognostic biomarkers in high grade serous ovarian cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430641/ https://www.ncbi.nlm.nih.gov/pubmed/34503204 http://dx.doi.org/10.3390/cancers13174394 |
work_keys_str_mv | AT lecuellejulie tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT boidotromain tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT mananethugo tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT derangerevalentin tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT albuissonjuliette tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT goussotvincent tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT arnouldlaurent tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT tharinzoe tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT raycoquardisabelle tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT ghiringhellifrancois tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT truntzercaroline tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer AT fumetjeandavid tcrclonalityandgenomicinstabilitysignaturesasprognosticbiomarkersinhighgradeserousovariancancer |